Simplex Trading’s Impax Laboratories, Inc. IPXL Stock Holding History

Simplex Trading’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-208	Closed	-$15K	–	7214
2017 Q3	$15K	Buy	208 +1	+0.5%	+$19	﹤0.01%	3452
2017 Q2	$43K	Buy	207 +185	+841%	+$2.73K	﹤0.01%	2543
2017 Q1	$2K	Sell	22 -65	-75%	-$785	﹤0.01%	5466
2016 Q4	$35K	Sell	87 -67	-44%	-$1.15K	﹤0.01%	2519
2016 Q3	$29K	Buy	154 +24	+18%	+$645	﹤0.01%	2610
2016 Q2	$26K	Buy	130 +59	+83%	+$1.92K	﹤0.01%	2689
2016 Q1	$20K	Buy	+71	New	+$2.5K	﹤0.01%	2824
2015 Q4	–	Sell	-19	Closed	-$13K	–	6605
2015 Q3	$13K	Buy	+19	New	+$856	﹤0.01%	3236
2015 Q2	–	Sell	-12	Closed	-$13K	–	6248
2015 Q1	$13K	Buy	+12	New	+$477	﹤0.01%	2744

Simplex Trading's IPXL Position: Q3 2017 in Review

Simplex Trading sold out of Impax Laboratories, Inc. (IPXL) in Q3 2017, closing a stake of 12,708 shares — an estimated $243K sold.

Simplex Trading first reported a position in IPXL in Q1 2015 and held it in 7 quarters. The position peaked at $528K in Q1 2017. 189 funds tracked by Wall St. Rank hold IPXL as of Q3 2017.

Simplex Trading reported no remaining Impax Laboratories, Inc. position as of Q3 2017 after selling out during the quarter.
Simplex Trading sold 12,708 Impax Laboratories, Inc. shares in Q3 2017, an estimated $243K.
Simplex Trading first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 7 quarters.
Simplex Trading's Impax Laboratories, Inc. position peaked at $528K in Q1 2017.
189 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2017.

Based on Simplex Trading's 13F filing for Q3 2017, filed 25 Oct 2017.